A Safe New Approach for CRISPR-Cas9 Gene Therapy in Humans


BioTechniques News

Off-target effects have delayed the use of CRISPR-Cas9 in humans, but researchers now suggest that using an engineered ribonucleoprotein will significantly reduce those risks. Learn more…
Full BioTechniques Article here

Powered by WPeMatico